Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Thomas Pretlow
Failure of Hormone Therapy in Prostate Cancer Involves Systematic Restoration of Androgen Responsive Genes and Activation of Rapamycin Sensitive Signaling
Oncogene
Cancer Research
Genetics
Molecular Biology
Related publications
Dysregulated Expression of Androgen-Responsive and Nonresponsive Genes in the Androgen-Independent Prostate Cancer Xenograft Model, CWR22-R
Nature Genetics
Genetics
Cost-Effectiveness Analysis of Abiraterone, Docetaxel or Placebo Plus Androgen Deprivation Therapy for Hormone-Sensitive Advanced Prostate Cancer
Einstein (São Paulo, Brazil)
Medicine
Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Explaining Hormone-Deprivation Therapy Failure in Prostate Cancer Patients
Expert Review of Endocrinology and Metabolism
Endocrinology
Metabolism
Diabetes
Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men With Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial
Clinical Cancer Research
Cancer Research
Oncology
Activation of mRNA Translation in Rat Cardiac Myocytes by Insulin Involves Multiple Rapamycin-Sensitive Steps
American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular Medicine
Physiology
Cardiology
New Possibilities of Combined Antiandrogen Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Onkourologiya
Oncology
Radiology
Urology
Nuclear Medicine
Nephrology
Imaging
Surgery
Chemohormonal Therapy for Metastatic Hormone-Sensitive Prostate Cancer: An Asian Perspective
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Clinical Outcomes of Anti-Androgen Withdrawal and Subsequent Alternative Anti-Androgen Therapy for Advanced Prostate Cancer Following Failure of Initial Maximum Androgen Blockade
Molecular and Clinical Oncology
Cancer Research
Oncology
